Effects of SGLT-2 inhibitors on clinical and biological hyperandrogenism and menstruation irregularities in patients with polycystic ovary syndrome: A systematic review of randomized trials

Effects of SGLT-2 inhibitors on clinical and biological hyperandrogenism and menstruation irregularities in patients with polycystic ovary syndrome: A systematic review of randomized trials

Introduction: Polycystic ovary syndrome is a common chronic condition characterized by insulin resistance and hyperandrogenism, leading to significant health risks and impaired quality of life. Sodium-glucose transporter type 2 inhibitors have shown promise in improving the metabolic profile of wome...

Full description

Saved in:

Bibliographic Details
Main Authors:	Houcem Elomma Mrabet, Houda Ben Salem, Taieb Ach, Asma Ben Abdelkarim, Wafa Alaya
Format:	Article
Language:	English
Published:	SAGE Publishing 2024-12-01
Series:	SAGE Open Medicine
Online Access:	https://doi.org/10.1177/20503121241308997
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Impact of non-severe infections on cortisol and thyroid stimulating hormone baseline levels in hospitalized patients: A monocentric cross-sectional study
by: Mrabet Houcem Elomma, et al.
Published: (2024-01-01)

Research hotspots of polycystic ovary syndrome and hyperandrogenism from 2008 to 2022: bibliometric analysis
by: Haijuan Liu, et al.
Published: (2024-12-01)

Effect of “DXB-2030,” a Polyherbal Formulation, on Experimental Polycystic Ovary Syndrome Associated with Hyperandrogenism
by: Mohammed Azeemuddin, et al.
Published: (2019-01-01)

Deciphering the Role of Androgen in the Dermatologic Manifestations of Polycystic Ovary Syndrome Patients: A State-of-the-Art Review
by: Ach Taieb, et al.
Published: (2024-11-01)

Effects of non-pharmacological interventions on biochemical hyperandrogenism in women with polycystic ovary syndrome: a systematic review and network meta-analysis
by: Qi Jin, et al.
Published: (2025-01-01)

Effects of Aerobic Exercise on Rats with Hyperandrogenic Polycystic Ovarian Syndrome
by: Na Li, et al.
Published: (2021-01-01)

IRREGULAR MENSTRUATION THERAPY WITH ACUPUNCTURE, POMEGRANATE PEEL AND GINGER HERBS
by: Sinta Diyah Dimyati, et al.
Published: (2020-07-01)

THERAPY FOR IRREGULAR MENSTRUATION WITH ACUPUNTURE AND HERBAL PEGAGAN (CENTELLA ASIATICA (L.))
by: Evin Dwi Prayuni, et al.
Published: (2019-01-01)

Effect of acupuncture on primary hypothyroidism and irregular menstruation in infertile women: a randomised controlled study
by: Eman Sedky Abdullah, et al.
Published: (2024-12-01)

Polycystic ovary syndrome (PCOS): progress towards a better understanding and treatment of the syndrome
by: Mimouni, Nour El Houda, et al.
Published: (2024-04-01)

Obesity and Polycystic Ovary Syndrome
by: Jin Ju Kim
Published: (2024-12-01)

Expression of SET Protein in the Ovaries of Patients with Polycystic Ovary Syndrome
by: Xu Boqun, et al.
Published: (2013-01-01)

Diagnosis and treatment of polycystic ovary syndrome
by: Ronelsys Martínez Martínez, et al.
Published: (2023-11-01)

The prevalence of polycystic ovaries in infertility by laparoscopy ‎
by: Tahereh Ziaie, et al.
Published: (2013-09-01)

New biomarkers for diagnosis of polycystic ovary syndrome
by: Farid I. Hassan, et al.
Published: (2023-04-01)

Impact of headache in women with polycystic ovary syndrome
by: Lina Zabulienë, et al.
Published: (2021-12-01)

Thiazolidinediones and Fertility in Polycystic Ovary Syndrome (PCOS)
by: Pascal Froment, et al.
Published: (2006-01-01)

Polycystic Ovary Syndrome May Be an Autoimmune Disorder
by: Hifsa Mobeen, et al.
Published: (2016-01-01)

Bariatric Surgery, Polycystic Ovary Syndrome, and Infertility
by: James Butterworth, et al.
Published: (2016-01-01)

Hyperandrogenism-Insulin Resistance-Acanthosis Nigricans Syndrome
by: A. H. Dédjan, et al.
Published: (2015-01-01)

Management of “hyperandrogenism” confounded by dermatology biotin prescriptions
by: Sumal S. Sundar, et al.
Published: (2024-12-01)

Extended High Frequency Audiometry in Polycystic Ovary Syndrome
by: Cuneyt Kucur, et al.
Published: (2013-01-01)

Mediators of Inflammation in Polycystic Ovary Syndrome in Relation to Adiposity
by: Thozhukat Sathyapalan, et al.
Published: (2010-01-01)

Obesity Differentially Affects Phenotypes of Polycystic Ovary Syndrome
by: Carlos Moran, et al.
Published: (2012-01-01)

Variation in Clinical Presentation, Metabolic Profile, Hormonal Parameters and Inflammatory Markers in Polycystic Ovary Syndrome Women with and without Polycystic Ovary Morphology Appearance
by: Sweekruti Jena, et al.
Published: (2023-04-01)

Ayurvedic Approaches to Holistic Management of Polycystic Ovary Syndrome (PCOS)
by: Ashvini D. Pardhekar, et al.
Published: (2024-12-01)

Mastalgia Assesment and Hormonal Correlations in Patients with Polycystic Ovary Syndrome
by: Emel Kıyak Çağlayan, et al.
Published: (2015-04-01)

Polycystic Ovary Syndrome and Reproductive Health: A Comprehensive Review
by: Ramadan S. Hussein, et al.
Published: (2024-12-01)

Association of SOGPI in mediating the effect of Phosphatidylcholine on polycystic Ovary Syndrome
by: Qian Guo, et al.
Published: (2024-12-01)

The potential role of uric acid in women with polycystic ovary syndrome
by: Zhentao Gong, et al.
Published: (2024-12-01)

Features of correction of metabolic disorders in women with polycystic ovary syndrome
by: O.V. Bulavenko, et al.
Published: (2024-10-01)

Proposal for an Educational Program for the Prevention of Complications of Polycystic Ovary Syndrome
by: Edison Sotalin Nivela, et al.
Published: (2024-01-01)

Health-related Quality of Life in Women with Polycystic Ovary Syndrome
by: Belén Carazo Hernández, et al.
Published: (2014-04-01)

Ovulation Induction Techniques in Polycystic Ovary Syndrome - Systematic Review
by: Daria Michałka, et al.
Published: (2025-01-01)

Cardiovascular Risk Biomarkers in Women with and Without Polycystic Ovary Syndrome
by: Manjula Nandakumar, et al.
Published: (2024-12-01)

The Prevalence of Polycystic Ovary Syndrome in Women with Idiopathic Intracranial Hypertension
by: Inbal Avisar, et al.
Published: (2012-01-01)

The role of immunity in insulin resistance in patients with polycystic ovary syndrome
by: Qixuan Zhang, et al.
Published: (2025-01-01)

Chiglitazar ameliorates dehydroepiandrosterone-induced polycystic ovary syndrome in rats
by: Fuzhen Zhao, et al.
Published: (2024-11-01)

Association of lipid profile and obesity in patients with polycystic ovary syndrome
by: Parveen Sadaf, et al.
Published: (2024-01-01)

An Adolescent With a Giant Ovarian Cyst and Hyperandrogenism: Case Report
by: Julio César Moreno-Alfonso, et al.
Published: (2025-01-01)